Trial intelligence / Profile preview

Safety of Definity on Pulmonary Hemodynamics

NCT00918866Phase 4Completed

Sponsor
Lantheus Holdings, Inc.
Start
Jul 2009
Primary completion
Dec 2009
Modality
Drug Delivery Systems
Countries
1
01

Overview

A Phase 4 trial of perflutren lipid microspheres, sponsored by Lantheus Holdings, Inc.. Started Jul 2009; status: completed.

02

Drugs

perflutren lipid microspheres

Beyond the preview

Go deeper on NCT00918866.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00918866.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call